The era of development is leading to a hazardous increase in environmental pollution, which is giving birth to a number of chronic respiratory diseases such as asthma and COPD and is resulting in both physical and psychological suffering for the patients. The global market for inhalation systems is growing rapidly because of increasing respiratory problems and is expected to have a high growth rate during the period from 2012 to 2018. The United States and Europe hold the maximum market share because these are industrialized countries with more environmental pollution.
View Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1355
Analysts predict that the global inhalation systems market will be fueled by the easy-to-use inhalation devices, quick delivery, affordability, and technological advancements in these systems that have made them convenient solutions for several users. The global market offers products such as metered dose inhalers, liquid droplet inhalers, dry powder inhalers, and nebulizers. The research indicates that the metered dose inhalers (MDI) hold a dominant share in the global market. They release pressurized gas as per a specific dosage upon activation by the user. This is followed by dry powder inhalers, which are used for treating cystic fibrosis of the lung.
Geographically, the global inhalation systems market is segmented into North America, Asia Pacific, Europe, and Rest of the World. Currently, North America and Europe hold a leading share in the global market due to the awareness about these systems and an access to better healthcare. However, analysts predict that Asia Pacific is also likely to emerge as the significant market as the region offers a huge population base with unmet medical needs. Furthermore, hazardous levels of pollution seen in developing nations of China, India, and Japan due to rapid industrialization and manufacturing activities is also likely to offer several lucrative opportunities to the overall market.
Some of the key players operating in the global inhalation systems market are Akela Pharma (Canada), Alkermes, Mankind, GlaxoSmithKline Plc (UK), AOP Orphan Pharmaceuticals, Consort Medical PLC (UK), DEY L.P. (USA), and Alpharx Inc. The research report profiles these players and provides a thorough assessment of the competitive landscape in the global inhalation systems market.
The document clearly explains the strategic mergers and acquisitions these players are planning in order to expand their geographical reach and product portfolio. The document also examines the business and marketing strategies of these players, their research and development activities, and their investments plans for the near future.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453